Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Astellas announced the expansion of its Top Management to include two new positions today, both of which will report directly to Chief Executive...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas" ) announced today that the United States ("U.S.") Food and Drug ...
The Astellas Global Health Foundation ("Foundation") announced today it will provide $2 million in emergency relief focused on improved healthcare...
With more and more Americans facing economic hardships as a result of the COVID-19 pandemic, Astellas has implemented changes to its patient...
Astellas Pharma US, ("Astellas") and the Astellas Global Health Foundation are each expanding support for global and local communities fighting...
Seattle Genetics, Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced...
The Astellas Global Health Foundation ("Foundation") and the Academic Model Providing Access to Healthcare (AMPATH), under the direction of the...
For the sixth consecutive year, Astellas has achieved a perfect score on the Human Rights Campaign Foundation's (HRC) annual Corporate Equality Index ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Xyphos Biosciences, Inc. (CEO: James Knighton, "Xyphos")...
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food ...
Astellas Venture Management (President: Shunichiro Matsumoto, Ph.D., MBA, "AVM"), a wholly-owned venture capital subsidiary of Astellas Pharma Inc....
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the presentation of new data in acute myeloid...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National Medical Products...
Astellas earned a spot on the 2019 Working Mother's Best Companies for Dads list for the first time for its leadership in paternity leave and Bridge...
Astellas was ranked in the Top 10 of the 2019 Working Mother "100 Best Companies" list for its leadership in the areas of women's career advancement, ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the Committee for Medicinal Products for...
Nearly 1,000 Astellas employees stepped away from the office today to volunteer across the United States as part of the 10th annual Changing Tomorrow ...
Astellas Venture Management, LLC (President: Shunichiro Matsumoto, Ph.D., MBA, "AVM"), a wholly-owned venture capital subsidiary of Astellas Pharma...
Astellas is proud to announce that Chelsea Glinski, executive director, Reimbursement Strategy will be recognized by the Healthcare Businesswomen's...
For the fifth consecutive year, Astellas has achieved a perfect score on the Human Rights Campaign Foundation's (HRC) annual Corporate Equality Index ...
Astellas US LLC and WiserCare, a company that develops healthcare decision support solutions, announced today a new collaboration focused on...
Astellas today announced that Lei Ding has been promoted to vice president, Payer Strategy, Contracts and Pricing. In this role, Ding will be...
Entre los diferentes tipos de cáncer que se presentan en Colombia, el cáncer de seno representa la primera causa de muerte para las mujeres y se...
Astellas today issued its third-annual Americas Corporate Social Responsibility (CSR) Report Card. The Report Card, which can be found here, outlines ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.